ZA200704727B - Novel drugs for treating respiratory diseases - Google Patents

Novel drugs for treating respiratory diseases

Info

Publication number
ZA200704727B
ZA200704727B ZA200704727A ZA200704727A ZA200704727B ZA 200704727 B ZA200704727 B ZA 200704727B ZA 200704727 A ZA200704727 A ZA 200704727A ZA 200704727 A ZA200704727 A ZA 200704727A ZA 200704727 B ZA200704727 B ZA 200704727B
Authority
ZA
South Africa
Prior art keywords
respiratory diseases
treating respiratory
novel drugs
drugs
novel
Prior art date
Application number
ZA200704727A
Inventor
Konetzki Ingo
Bouyssou Thierry
Lustenberger Philipp
Schnapp Andreas
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA200704727B publication Critical patent/ZA200704727B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/5381,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
ZA200704727A 2005-02-24 2007-06-14 Novel drugs for treating respiratory diseases ZA200704727B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005008921A DE102005008921A1 (en) 2005-02-24 2005-02-24 New drugs for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
ZA200704727B true ZA200704727B (en) 2008-09-25

Family

ID=36179764

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704727A ZA200704727B (en) 2005-02-24 2007-06-14 Novel drugs for treating respiratory diseases

Country Status (26)

Country Link
US (3) US20060189605A1 (en)
EP (1) EP1856070B1 (en)
JP (1) JP4950075B2 (en)
KR (1) KR20070110386A (en)
CN (1) CN101128444A (en)
AR (1) AR055562A1 (en)
AT (1) ATE517877T1 (en)
AU (1) AU2006218010B2 (en)
BR (1) BRPI0607258A2 (en)
CA (1) CA2598914A1 (en)
DE (1) DE102005008921A1 (en)
DK (1) DK1856070T3 (en)
EA (1) EA012439B1 (en)
ES (1) ES2370653T3 (en)
IL (1) IL185444A0 (en)
MX (1) MX2007010363A (en)
MY (1) MY146802A (en)
NO (1) NO20073176L (en)
NZ (1) NZ561743A (en)
PE (1) PE20061097A1 (en)
PL (1) PL1856070T3 (en)
TW (1) TWI369988B (en)
UA (1) UA90504C2 (en)
UY (1) UY29394A1 (en)
WO (1) WO2006089859A1 (en)
ZA (1) ZA200704727B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005008921A1 (en) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drugs for the treatment of respiratory diseases
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
UY30550A1 (en) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int NEW BETA-AGANISTAS ENANTIOMÉRICAMENTE PUROS, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS
PE20080425A1 (en) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int AEROSOL FORMULATION FOR INHALATION OF BETA-AGONISTS
UY30552A1 (en) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int PHARMACOLOGICAL COMBINATIONS BASED ON SUBSTITUTED DERIVATIVES OF THE N- (5- {2- [1,1-DIMETIL-PROPILAMINO] -1-HIDROXI-METIL} -2-HYDROXI-PHENYL) -METANSULPHONAMIDE AND APPLICATIONS
WO2008023001A1 (en) * 2006-08-22 2008-02-28 Boehringer Ingelheim International Gmbh Powder formulations for inhalation containing enantiomerically pure beta-agonists
EP2093219A1 (en) * 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Crystalline enantiomer free salt form of a betamimetic and its use as medicine
GB201217330D0 (en) * 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
DK3236983T3 (en) 2014-12-24 2019-07-15 Kither Biotech S R L HOWEVER, UNKNOWN PI3K GAMMA INHIBITOR SPEED FOR TREATMENT OF DISEASES IN THE RESPIRATORY SYSTEM

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026534A1 (en) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-BENZOXAZINE-2-ONE, THEIR PRODUCTION AND USE
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
DE3609152A1 (en) * 1986-03-19 1987-09-24 Bayer Ag METHOD FOR PRODUCING THE (-) - ANTIPODE OF (E) -1-CYCLOHEXYL-4,4-DIMETHYL-3-HYDROXY-2- (1,2,4-TRIAZOL-1-YL) -PENT-1-ENS
PL1613315T3 (en) * 2003-04-04 2009-07-31 Novartis Ag Quinoline-2-one-derivatives for the treatment of airways diseases
DE102004003428A1 (en) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting beta-2 agonists, and their use as pharmaceuticals
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102005008921A1 (en) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drugs for the treatment of respiratory diseases
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
PE20080425A1 (en) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int AEROSOL FORMULATION FOR INHALATION OF BETA-AGONISTS
UY30552A1 (en) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int PHARMACOLOGICAL COMBINATIONS BASED ON SUBSTITUTED DERIVATIVES OF THE N- (5- {2- [1,1-DIMETIL-PROPILAMINO] -1-HIDROXI-METIL} -2-HYDROXI-PHENYL) -METANSULPHONAMIDE AND APPLICATIONS

Also Published As

Publication number Publication date
IL185444A0 (en) 2008-01-06
EP1856070A1 (en) 2007-11-21
BRPI0607258A2 (en) 2009-08-25
ATE517877T1 (en) 2011-08-15
EP1856070B1 (en) 2011-07-27
MX2007010363A (en) 2007-09-25
EA012439B1 (en) 2009-10-30
AR055562A1 (en) 2007-08-22
JP4950075B2 (en) 2012-06-13
AU2006218010B2 (en) 2013-02-14
CN101128444A (en) 2008-02-20
DK1856070T3 (en) 2011-09-26
EA200701615A1 (en) 2008-02-28
NZ561743A (en) 2009-09-25
KR20070110386A (en) 2007-11-16
US20110053926A1 (en) 2011-03-03
NO20073176L (en) 2007-09-17
CA2598914A1 (en) 2006-08-31
MY146802A (en) 2012-09-28
UY29394A1 (en) 2006-10-02
ES2370653T3 (en) 2011-12-21
US20060189605A1 (en) 2006-08-24
PE20061097A1 (en) 2006-11-14
AU2006218010A1 (en) 2006-08-31
WO2006089859A1 (en) 2006-08-31
DE102005008921A1 (en) 2006-08-31
JP2008531518A (en) 2008-08-14
PL1856070T3 (en) 2011-12-30
TW200640465A (en) 2006-12-01
US20090105236A1 (en) 2009-04-23
UA90504C2 (en) 2010-05-11
TWI369988B (en) 2012-08-11

Similar Documents

Publication Publication Date Title
HUS1500058I1 (en) Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL181049A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL180931A0 (en) Medicaments for treating chronic respiratory disease
EP1962869A4 (en) Treatment of respiratory diseases
IL178815A0 (en) The treatment of respiratory disease
IL177663A0 (en) Benzoxazine for treating respiratory tract diseases
ZA200801667B (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
IL185444A0 (en) Novel drugs for treating respiratory diseases
GB0410399D0 (en) The treatment of respiratory disease
IL197125A0 (en) Drug combinations for treating airway diseases
EP1871344A4 (en) Inhalable drug
GB0701456D0 (en) Treatment for respiratory disease
EP1731171A4 (en) Preventive/remedy for respiratory diseases
EP1942909A4 (en) Methods for treating respiratory disorders
EP2059238A4 (en) Therapeutic compounds for diseases and disorders
HK1120034A1 (en) Pharmaceuticals for treating or preventing oral diseases
EP1927353A4 (en) Remedy for corneal diseases
GB0520152D0 (en) Treatment of respiratory disease
ZA200802948B (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
GB0524945D0 (en) Medicament inhaler
GB0512757D0 (en) Treatment of respiratory disorders
GB0420867D0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases